High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$6K
$6,734
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2026-03-20
$2,669
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2026-03-20 | $2,669 | S | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2026-03-20
$689
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2026-03-20 | $689 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Equity Compensation
2025-12-20
$0
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Equity Compensation
|
2025-12-20 | $0 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2025-12-20
$2,691
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2025-12-20 | $2,691 | S | Form 4 |
|
FDMT
M
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Equity Compensation
2025-12-20
$0
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Equity Compensation
|
2025-12-20 | $0 | M | Form 4 |
|
FDMT
S
4D Molecular Therapeutics, Inc.
Gupta Ashoo
• Officer • VP, Finance and Controller
Sell to Cover
2025-12-20
$686
|
||||||
| FDMT |
4D Molecular Therapeutics, Inc.
|
Officer • VP, Finance and Controller
Sell to Cover
|
2025-12-20 | $686 | S | Form 4 |